- Home
- CADL vs PTMN Comparison
CADL vs PTMN Comparison
Compare CADL & PTMN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CADL
- PTMN
- Stock Information
- Founded
- CADL 1999
- PTMN 2006
- Country
- CADL United States
- PTMN United States
- Employees
- CADL N/A
- PTMN N/A
- Industry
- CADL Biotechnology: Pharmaceutical Preparations
- PTMN Finance: Consumer Services
- Sector
- CADL Health Care
- PTMN Finance
- Exchange
- CADL Nasdaq
- PTMN Nasdaq
- Market Cap
- CADL 159.1M
- PTMN 156.9M
- IPO Year
- CADL 2021
- PTMN N/A
- Fundamental
- Price
- CADL $6.60
- PTMN $16.51
- Analyst Decision
- CADL Strong Buy
- PTMN Hold
- Analyst Count
- CADL 1
- PTMN 3
- Target Price
- CADL $11.00
- PTMN $19.33
- AVG Volume (30 Days)
- CADL 8.6M
- PTMN 74.1K
- Earning Date
- CADL 11-14-2024
- PTMN 11-07-2024
- Dividend Yield
- CADL N/A
- PTMN 16.71%
- EPS Growth
- CADL N/A
- PTMN N/A
- EPS
- CADL N/A
- PTMN 0.39
- Revenue
- CADL N/A
- PTMN $65,828,000.00
- Revenue This Year
- CADL N/A
- PTMN N/A
- Revenue Next Year
- CADL N/A
- PTMN N/A
- P/E Ratio
- CADL N/A
- PTMN $42.79
- Revenue Growth
- CADL N/A
- PTMN N/A
- 52 Week Low
- CADL $1.02
- PTMN $16.34
- 52 Week High
- CADL $14.60
- PTMN $20.84
- Technical
- Relative Strength Index (RSI)
- CADL 55.49
- PTMN 31.19
- Support Level
- CADL $4.42
- PTMN $16.50
- Resistance Level
- CADL $7.28
- PTMN $16.95
- Average True Range (ATR)
- CADL 1.35
- PTMN 0.24
- MACD
- CADL 0.26
- PTMN 0.03
- Stochastic Oscillator
- CADL 22.48
- PTMN 19.10
About CADL Candel Therapeutics Inc.
Candel Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing and commercializing viral immunotherapies to help patients fight cancer. The company has established two clinical-stage viral immunotherapy platforms based on novel, genetically modified adenovirus and herpes simplex virus (HSV) constructs, respectively.
About PTMN Portman Ridge Finance Corporation
Portman Ridge Finance Corp Inc is a non-diversified closed-end investment company. The company originates, structures, and invests in secured term loans, bonds or notes, and mezzanine debt primarily in privately-held middle market companies but may also invest in other investments such as loans to publicly traded companies, high-yield bonds, and distressed debt securities. The company's investment objective in the Debt securities portfolio is to generate current income and, to a lesser extent, capital appreciation from the investments in senior secured term loans, mezzanine debt, and selected equity investments in privately-held middle market companies.